(Q82249175)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

IL6 as a mediator of insulin resistance: fat or fiction? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

T L Allen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M A Febbraio

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

10 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

399-402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012010%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-009-1627-x

15 January 2020

exact match

0 references

cites work

Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice.

1 reference

12 December 2020

AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment

1 reference

12 December 2020

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

1 reference

12 December 2020

Human IL6 enhances leptin action in mice

1 reference

12 December 2020

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

1 reference

12 December 2020

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

1 reference

12 December 2020

Interleukin-6 induces cellular insulin resistance in hepatocytes

1 reference

12 December 2020

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo

1 reference

12 December 2020

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

12 December 2020

How obesity causes diabetes: not a tall tale

1 reference

12 December 2020

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

1 reference

12 December 2020

Inflammation, stress, and diabetes

1 reference

12 December 2020

Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction

1 reference

12 December 2020

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

1 reference

12 December 2020

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

1 reference

12 December 2020

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

1 reference

12 December 2020

Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure.

1 reference

12 December 2020

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

12 December 2020

Interleukin-6 Regulates Human Adipose Tissue Lipid Metabolism and Leptin Productionin Vitro

1 reference

12 December 2020

Effects of acute exercise and training on insulin action and sensitivity: focus on molecular mechanisms in muscle

1 reference

12 December 2020

Intracerebroventricular interleukin-6 treatment decreases body fat in rats

1 reference

12 December 2020

Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity.

1 reference

12 December 2020

Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha

1 reference

12 December 2020

Interleukin-6 is a centrally acting endogenous pyrogen in the rat

1 reference

12 December 2020

gp130 receptor ligands as potential therapeutic targets for obesity

1 reference

12 December 2020

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

1 reference

12 December 2020

Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats

1 reference

12 December 2020

Interleukin-6-deficient mice develop mature-onset obesity

1 reference

12 December 2020

CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.

1 reference

12 December 2020

Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat.

1 reference

12 December 2020

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

1 reference

12 December 2020